One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donorsDietger Niederwieser, Wael Saber, Amir Ali Hamidieh et al.|Haematologica|2021Cited by 236
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis CongenitaShahinaz M. Gadalla, Sharon A. Savage, Carmem Sales‐Bonfim et al.|Biology of Blood and Marrow Transplantation|2013Cited by 130
Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant ResearchMichelle Long Schoettler, Sumithira Vasu, Enric Carreras et al.|Transplantation and Cellular Therapy|2022Cited by 130
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 UpdateSeth J. Rotz, Rachel Phelan, Neel S. Bhatt et al.|Transplantation and Cellular Therapy|2024Cited by 62
The economics of haemophilia prophylaxis: governmental and insurer perspectives. PROCEEDINGS OF THE SECOND INTERNATIONAL PROPHYLAXIS STUDY GROUP (IPSG) SYMPOSIUMB. M. Feldman, V. Blanchette, Louis M. Aledort et al.|Haemophilia|2007Cited by 22